Jagsonpal Pharmaceuticals Limited
NSE: JAGSNPHARM | Information Technology
Market Fundamentals
Stock Intelligence & News
Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Watch out for these 15 companies, including 4 banks, in today’s trade
HDFC Bank, Yes Bank, Axis Bank, Bandhan Bank, RailTel Corp, Jagsonpal Pharmaceuticals, SIS Limited, BSE, Oberoi Realty, RITES, Accord Transformers & Switchgear, WeWork India, ARSS Infrastructure Projects, Schneider Electric stocks to be in focus today
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Infinity Holdings has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Ltd has informed the Exchange about Issue Summary Document (ISD) for Buy-back of Post Issue Stage through Tender offer |SUBJECT: ISD for Buyback-Tender Offer
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Resignation of Resignation of an Independent Director. as Non- Executive Independent Director of the company w.e.f. May 18, 2026. |SUBJECT: Resignation
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on 27-Apr-2026 for Dividend |SUBJECT: Outcome of Board Meeting-XBRL
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 27, 2026, titled "Press Release for Audited Financial Results for quarter and year ended March 31, 2026". |SUBJECT: Press Release
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited has informed the Exchange about Presentation |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Get instant alerts when JAGSNPHARM breaks news
Join investors who track Jagsonpal Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for JAGSNPHARM?
JAGSNPHARM is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Jagsonpal Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding JAGSNPHARM to your custom watchlist.